Tropical Journal of Pharmaceutical Research
Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria
Vol. 14, No. 2, 2015, pp. 271-277
Bioline Code: pr15037
Full paper language: English
Document type: Research Article
Document available free of charge
Tropical Journal of Pharmaceutical Research, Vol. 14, No. 2, 2015, pp. 271-277
© Copyright 2015 - Tropical Journal of Pharmaceutical Research
Synthesis of 1-Substituted-4-(Pyridin-4-yl) [1,2,4] Triazolo [4,3-a] Quinazolin-5(4H)-ones as a New Class of H1- Antihistaminic Agents|
Gobinath, M.; Subramanian, N.; Alagarsamy, V.; Nivedhitha, S. & Raja Solomon, V.
Purpose: To synthesize a new series of 1-substituted-4-(pyridin-4-yl) [1,2,4] triazolo[4,3-a]quinazolin-
5(4H)-ones and evaluate them for H1-antihistaminic activity with negligible side effects in guinea pigs.
Methods: The synthesized compounds were characterized by Infrared spectroscopy (IR), proton
nuclear magnetic resonance (1H-NMR) and mass spectrometry (MS) data. The purity of the compounds
was determined by elemental analysis. The antihistaminic activity of the compounds was evaluated in
guinea pigs by histamine-induced bronchoconstriction method.
Results: Among the series, 1-methyl-4-(pyridin-4-yl) [1,2,4] triazolo [4,3-a] quinazolin-5(4H)-one (S5)
was the most potent with 72.85 % protection and its potency was comparable to that of the reference,
chlorpheniramine maleate (70.09 %). Interestingly, the sedative property of compound S5 was
negligible (5.09 %) when compared to chlorpheniramine maleate (29.58 %).
Conclusion: Compound S5 can serve as a lead molecule for further development into a new class of
Quinazolin-5-ones; Antihistaminic activity; Histamine; Bronchoconstriction
Alternative site location: http://www.tjpr.org